Printer Friendly
The Free Library
19,607,050 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

FDA transforming CDER in response to IOM report.


FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 Oct. 4 announced the award of a two-year, $1.5 million contract to the Center for Professional Development (CPD CPD citrate phosphate dextrose; see anticoagulant citrate phosphate dextrose solution, under solution.
Cephalopelvic disproportion (CPD) 
) to assist with the transformation of FDA's Center for Drugs (CDER CDER Center for Drug Evaluation and Research (US FDA)
CDER Centre de Développement des Energies Renouvelables (French)
CDER Client Development and Evaluation Report
), with a particular focus on steps to improve workplace leadership, empower staff, and establish more effective business practices.

The award to Oakland, CA-based CPD is part of FDA's ongoing response to a report issued in 2006 by the Institute of Medicine (IOM IOM

See: Index and Option Market
). Under the contract, CPD will help in the development of practical strategies, including training, tools, and processes that will strengthen CDER's organizational effectiveness Organizational effectiveness is the concept of how effective an organization is in achieving the outcomes the organization intends to produce. The idea of organizational effectiveness is especially important for non-profit organizations as most people who donate money to non-profit  and reaffirm its mission of advancing and protecting the public health.

"This transformative program will provide CDER with the tools and expertise necessary to create a sustainable environment of open and transparent communication, collaborative decision-making, and improved morale and staff retention," said Janet Woodcock woodcock: see snipe.
woodcock

Any of five species (family Scolopacidae) of plump, sharp-billed migratory birds of damp, dense woodlands in North America, Europe, and Asia.
, M.D., FDA's deputy commissioner for scientific and medical programs, and acting center director.

The IOM report, "The Future of Drug Safety--Promoting and Protecting the Health of the Public," identified workplace culture issues in CDER and recommended participation of external management consultants to develop a comprehensive strategy to address them.

Over the past year, FDA said CDER carefully evaluated options and developed a scope of work to solicit the best outside experts to assist in transforming the workplace environment. The entire workforce of about 2,300 in the Center will be included in the workplace transformation effort.

CPD will work with CDER's senior management team and a cross-sectional working group of Center employees to assess the center's organizational culture This article or section is written like an .
Please help [ rewrite this article] from a neutral point of view.
Mark blatant advertising for , using .
, identify characteristics and a vision for CDER's desired culture, and develop a plan for implementation and follow-up.

The CPD contract runs through Sept. 20, 2009.
COPYRIGHT 2007 Washington Information Source, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:FDA reform; Food and Drug Administration; Center for Drugs; Institute of Medicine
Publication:Adverse Event Reporting News
Article Type:Brief article
Geographic Code:1USA
Date:Oct 8, 2007
Words:284
Previous Article:SAEs, related deaths more than double from '98-'05, outpacing scrips written.
Next Article:Nominations sought for Reagan-Udall Foundation.
Topics:



Related Articles
Senate HELP Committee holds hearing on creating '21st century FDA'; Kennedy vows oversight in '07.
FDA embraces most IOM drug safety proposals.
FDA piloting safety studies of NMEs, revamping AERS, based on IOM recommendations.
FDA vows transformation, better drug safety.
Drug safety requires independent authority.
Premiere issue of FDA Drug Safety Newsletter released.
Sentinel initiative to gather public, private data on medical product reactions.
Woodcock named permanent CDER director--again.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles